# Why does TB-500 research come only from animals and cells?

Published November 14, 2026 · Updated November 14, 2026 · Data as of October 30, 2026

PepBank's records hold no result from a study in people for [TB-500](https://pepbank.io/p/tb-500). [1] They hold 22 findings in animals and 14 laboratory findings, as of October 30, 2026. [1] A trial registry lists 1 trial of TB-500 in people. [1] In rats with repaired Achilles tendons, TB-500 increased maximum load to failure compared with controls. [2] PepBank's regulatory record lists TB-500 as not approved for any use. [3]

## Key points

- PepBank's records hold no result from a study in people for TB-500. A trial registry lists 1 trial of TB-500 in people. [1]
- PepBank holds 22 findings in animals and 14 laboratory findings in cells or tissue for TB-500. [1]
- In rats with repaired Achilles tendons, TB-500 increased maximum load to failure compared with controls. [2]
- In 5xFAD mice, TB-500 and Ac-SDKP improved maze and object recognition performance and reduced glial activation. [4]
- In rats treated with TB-500, the metabolite Ac-LKK was detected up to 72 hours. [5]
- PepBank's regulatory record lists TB-500 as not approved for any use. [3]

## What is TB-500 in PepBank's record?

In horses, researchers gave [TB-500](https://pepbank.io/p/tb-500) as N-acetylated LKKTETQ. [6] TB-500 is one of the [peptides in PepBank](https://pepbank.io/peptides). [1] PepBank's regulatory record lists TB-500 as not approved for any use, as of October 30, 2026. [3]

Curo, a peptide shop with the same owner as PepBank, sells TB-500. [See TB-500 at Curo](https://curo.you/products/tb-500-5mg?utm_source=pepbank&utm_medium=blog)

## Has TB-500 been studied in people?

PepBank's records hold no result from a study in people for TB-500. A trial registry lists 1 trial of TB-500 in people. [1]

PepBank holds 22 findings in animals from 6 publications, and 14 laboratory findings in cells or tissue from 4 publications. [1] It holds no findings predicted by a computer model. [1] [The studies of TB-500](https://pepbank.io/p/tb-500/studies) in PepBank hold 36 results from 7 studies that gave the peptide. [1]

## What did horse and rat studies find in blood and urine?

In a study in horses, researchers gave TB-500 under the skin to two thoroughbred geldings. They then detected N-acetylated LKKTETQ and its metabolite N-acetylated LK in the plasma of the horses. [7] In horses, a test method confirmed N-acetylated LKKTETQ and its metabolites in both urine and plasma. [6]

In rats treated with TB-500, Ac-LK was the main metabolite and had the highest levels in the first hours. [5] In rats, the study called Ac-LKK a long-term metabolite. It was detected up to 72 hours. [5]

## What did TB-500 do in mice with amyloid plaques?

In 5xFAD mice, TB-500 and another peptide, Ac-SDKP, improved performance in the Morris water maze and in novel object recognition. [4] In 5xFAD mice, the two peptides markedly reduced glial activation and neuronal apoptosis on immunohistochemistry. [4]

In 5xFAD mice, the peptides restored axonal density in the perirhinal cortex and attenuated plaque-associated dystrophic neurites. [4] In 5xFAD mice, they did not change hippocampal beta-amyloid (Aβ) burden. [4]

In a laboratory study in nerve cells treated with an Aβ fragment, TB-500 and Ac-SDKP restored cell viability and reduced neurite atrophy. [4] In microglia cells, the peptides suppressed nitric oxide production after lipopolysaccharide treatment. In these cells, they also reduced expression of pro-inflammatory cytokines. [4]

## What did the rat Achilles tendon study find?

In rats with repaired Achilles tendons, TB-500 increased maximum load to failure compared with controls. [2] In rats, TB-500 also lowered both the Bonar and the Movin histopathology scores compared with controls. [2] In rats, collagen type III expression differed significantly among groups, but the study did not state the direction for TB-500. [2]

In rats, Sirius red birefringence showed more organized type I collagen in treatment groups, particularly with TB-500. [2] In rats, collagen type I expression did not differ significantly among groups. [2] In rats, giving [BPC-157 and TB-500](https://pepbank.io/compare/bpc-157-vs-tb-500) together gave no additional benefit over either agent alone. [2]

## What did the corneal hydrogel studies find?

In animals with an alkali burn of the cornea, a TB-500 peptide hydrogel significantly sped epithelial regeneration and reduced inflammation. [8] In animals, the hydrogel also improved corneal barrier function. [8]

In a laboratory study in human corneal stromal fibroblasts, the hydrogel increased myofibroblastic differentiation and cytoskeletal reorganization. [8] In human corneal epithelial cells, it promoted tight junction recovery. [8]

## What amounts did the animal studies use?

The horse study and the rat tendon study each reported a studied amount in animals. [2, 7] The horse study gave TB-500 under the skin (subcutaneous). The rat study gave it into the abdomen (intraperitoneal). [2, 7]

| Kind | Dose | Species | Route | Design | Source |
| --- | --- | --- | --- | --- | --- |
| Studied dose | 10 mg N-acetylated LKKTETQ | horse | subcutaneous | animal in vivo | [7] |
| Studied dose | 60 µg/kg/day | rat | intraperitoneal | animal in vivo | [2] |

## What can these animal results not show about people?

The TB-500 findings in PepBank come from studies in horses, in rats, in mice and in cells. [1, 4, 5, 7] PepBank holds 0 publications with findings in people for TB-500, and no findings predicted by a computer model. [1]

A trial registry lists 1 trial of TB-500 in people, as of October 30, 2026. [1] PepBank's records hold no result from a study in people for TB-500 yet. [1]

## FAQ

### Is TB-500 approved for human use?

PepBank's regulatory record lists TB-500 as not approved for any use, in all places the record covers, as of October 30, 2026. [3] PepBank's records hold 0 findings in people for TB-500. [1] A trial registry lists 1 trial of TB-500 in people, and PepBank's records show no published result from it yet. [1]

### How is TB-500 detected in horse urine and plasma?

In horses given a single dose of TB-500, a test method confirmed N-acetylated LKKTETQ and its metabolites in urine and plasma. [6] In a study in horses given TB-500 under the skin, its metabolite N-acetylated LK was found in plasma. [7] In rats, Ac-LK was the main early metabolite and Ac-LKK was detected up to 72 hours. [5]

### Does TB-500 help wound healing in cell studies?

In fibroblast cells, parent TB-500 showed no significant wound healing activity compared with control. Only its metabolite Ac-LKKTE did. [5] In fibroblasts in a laboratory study, TB-500 and its metabolites showed no cytotoxicity. [5] In human corneal cells, a TB-500 hydrogel promoted cell migration and proliferation. [8]

## Sources

1. TB-500 in PepBank. PepBank, 2026-10-30. https://pepbank.io/p/tb-500
2. Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study. Joint diseases and related surgery, 2026-07-23. https://pubmed.ncbi.nlm.nih.gov/42542926/ PMID 42542926. Evidence class: animal.
3. TB-500: regulatory status in PepBank. PepBank, 2026-10-30. https://pepbank.io/p/tb-500
4. Thymosin β4-derived peptides alleviate neuroinflammation and neurite atrophy in both in vitro models and in vivo 5 × FAD mice: A potential therapy for memory improvement in Alzheimer's disease. International immunopharmacology, 2025-12-23. https://pubmed.ncbi.nlm.nih.gov/41443105/ PMID 41443105. Evidence class: animal, laboratory.
5. Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2024-02-07. https://pubmed.ncbi.nlm.nih.gov/38382158/ PMID 38382158. Evidence class: animal, laboratory.
6. Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry. Journal of chromatography. A, 2012-09-23. https://pubmed.ncbi.nlm.nih.gov/23084823/ PMID 23084823. Evidence class: animal.
7. Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry. Analytical and bioanalytical chemistry, 2013-01-15. https://pubmed.ncbi.nlm.nih.gov/23318763/ PMID 23318763. Evidence class: animal.
8. Alkaline Phosphatase-Triggered Spatiotemporal Repair of Corneal Injury with TB500 Peptide Hydrogel. ACS applied materials & interfaces, 2025-12-08. https://pubmed.ncbi.nlm.nih.gov/41359360/ PMID 41359360. Evidence class: animal, laboratory.

How this article is made: PepBank writes its articles from the studies and records in its database. Each claim links to its source. [Read how PepBank collects and classes evidence.](https://pepbank.io/methods)

Canonical: https://pepbank.io/blog/why-does-tb-500-research-come-only-from-animals-and-cells

This is not medical advice.
